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Mouse mammary tumor virus proviral DNA is endogenous to most inbred strains of mice but in many strains
is not transcriptionally active. This inactivity may be due to defects in the proviruses themselves or to position
effects mediated by DNA sequences flanking the proviral units. The transcriptional competence of long terminal
repeats (LTRs) derived from endogenous proviral DNA at genetic loci Mtv-8, Mtv-9, and Mtv-17 of the C57BL/
6 mouse strain was examined with a transient transfection assay in which gene expression was monitored by
expression of chloramphenicol acetyltransferase. LTRs from Mtv-8 and Mtv-9 were able to direct glucocorti-
coid-induced chloramphenicol acetyltransferase expression in this assay, while the LTR from Mtv-17 was only
about 5% as effective. Analysis of chimeric LTRs indicated that the glucocorticoid-inducible transcriptional
enhancer element within the Mtv-17 LTR is active when linked to a functional promoter from Mtv-8, whereas
the promoter from Mtv-17 is defective in directing hormone-induced gene expression, even when linked to the
Mtv-8 glucocorticoid-responsive enhancer. The DNA sequence of transcriptional control regions of the LTRs of
all three endogenous proviral units was determined; this analysis revealed that the source of the defect in
Mtv-17 is a single G-to-A transition at position-75 with respect to the site of transcription initiation that resides
within the previously defined binding site for the transcription factor nuclear factor 1. Competition
experiments with a gel electrophoresis mobility shift assay indicated that the affinity of nuclear factor 1 for DNA
derived from Mtv-17 is significantly less than for comparable sequences derived from Mtv-8.
Endogenous copies of the proviral DNA of mouse mam-
mary tumor virus (MMTV) are present as stable genetic
elements in the germ line DNA of most common laboratory
strains of mice (28). Although most of this endogenous
MMTV DNA is apparently organized into complete proviral
units, the proviruses appear in most cases to be transcrip-
tionally inactive (35, 64). Notable exceptions to this rule are
the endogenous proviruses at genetic loci Mtv-1 and Mtv-2,
which have been shown to encode infectious virions and to
contribute to the onset of mammary tumorigenesis in several
inbred strains (39, 62, 63, 65). Other endogenous proviral
units have been reported as transcriptionally active in some
tissues or in specific cultured cell lines (31, 35, 46, 51),
indicating that at least some endogenous proviruses are
transcriptionally competent.
The molecular basis for the transcriptional inactivity of
endogenous MMTV proviral DNA and the mechanisms by
which it can become activated are not known. In some cases
transcriptional inactivity may be maintained by position
effects of the sequences flanking the provirus; it has been
shown that the site of chromosomal insertion can play a
major role in the transcription of an exogenously acquired
MMTV provirus (12, 60), and transcription from the nor-
mally inactive Mtv-8 provirus has been demonstrated when
its chromosomal context is altered by integration at new
genomic sites by stable transformation of cloned Mtv-8 DNA
(8, 23). It is also possible that transcriptional inactivity of
some endogenous proviral units is due to defective MMTV
sequence elements necessary for initiation of RNA synthe-
sis. These elements include the transcriptional promoter; a
glucocorticoid-responsive enhancer termed the glucocorti-
coid response element (GRE), which mediates the hormone
inducibility of viral transcription (for a review, see reference
* Corresponding author.
66) and serves as a binding site for the purified glucocorticoid
receptor protein in vitro (15, 17, 47-49, 56, 57); and a recently
characterized negative transcriptional regulatory element
(NRE) which mediates repression of the basal activity of the
MMTV promoter and increases the ratio of gene expression
observed in the presence and absence of hormone (42).
In this study we have examined the transcriptional activity
of four long terminal repeats (LTRs) derived from three
endogenous copies of MMTV proviral DNA endogenous to
C57BL/6 mice. Using a transient transfection assay, we have
shown that LTRs derived from the endogenous proviruses at
genetic loci Mtv-8 and Mtv-9 can support glucocorticoid-
induced transcription but that the provirus from locus Mtv-
17 cannot; the defect in this provirus is due to a single G-to-A
transition in the DNA sequence element that serves as a
binding site for the transcription factor nuclear factor 1
(NF-1), and the affinity of NF-1 for the altered sequences is
significantly diminished by this transition.
MATERIALS AND METHODS
Plasmid constructions. Restriction endonucleases and
modifying enzymes (New England Biolabs or Bethesda
Research Laboratories) were used according to the suppli-
er's recommendations.
Plasmids pLV8.5 and pLV8.3 contain the 5' and 3' LTRs,
respectively, from the provirus at Mtv-8, while the 3' LTRs
from proviruses at Mtv-9 and Mtv-17 are in pLV9.3 and
pLV17.3. These plasmids were constructed as follows. The
3' LTRs of MMTV DNA at genetic loci Mtv-8, Mtv-9, and
Mtv-17 and the 5' LTR from Mtv-8, previously cloned from
the C57BL/6 cell line TlMl (53), were subcloned as AvaI-
to-BstEII restriction fragments (see Fig. 1). These isolated
fragments were treated with the Klenow fragment of Esch-
erichia coli DNA polymerase I (Bethesda Research Labora-
tories) in the presence of deoxynucleotide triphosphates to
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fill in protruding single-stranded termini. Synthetic HindIIl
linkers were then ligated to the blunt-ended fragments by
using T4 DNA ligase (Bethesda Research Laboratories); the
added linker sequences were 10 base pairs (bp) in length for
the LTR from Mtv-9 and the 5' LTR of Mti-8 and 17 and 19
bp for the 3' LTR from Mt'-17 and 3' LTR from Mtv-8,
respectively. These modified LTR sequences were inserted
in the appropriate orientation into plasmid vector pMT2 (42),
which has a unique HinidIII restriction site immediately
upstream of the chloramphenicol acetyltransferase (CAT)
gene and simian virus 40-derived sequences encoding the
small-t intron and poly(A) addition (16).
Plasmids pLV.G8.P8, pLV.G8.P17, and pLV.G17.P8 con-
tained chimeric LTR sequences and were made as follows.
Saui3A-HindIII restriction fragments containing the MMTV
promoters (see Fig. 2) from LTRs in pLV8.5 and pLV17.3
were isolated and ligated into the BglII-HinzdIII sites of a
CAT vector analogous to pMT2 (42) but containing both
BglII and HinidIII sites immediately 5' of the CAT coding
sequences. The MMTV promoters, minus most GRE se-
quences, were thus inserted in a position to drive synthesis
of CAT; these insertions resulted in the retention of the
unique BglII site immediately 5' of the MMTV promoter.
The 344-bp Sau3A fragment containing most of the GRE
(Fig. 1) from MtW -8 was then ligated into the unique BgIII site
of plasmids containing both promoters to generate
pLV.G8.P8, in which both GRE and promoter were derived
from Mt'-8, and pLV.G8.P17, in which the GRE-containing
fragment was derived from MtW-8 and the promoter-con-
taining fragment was derived from MtW-17. In similar fash-
ion, the 344-bp GRE fragment from MtW-17 was inserted into
the BgIII site of the plasmid containing the Mt.-8 promoter
to generate pLV.G17.P8. These chimeric LTRs were then
sequenced on double-stranded plasmid DNA to verify the
origin of the GRE and promoter sequences and the orienta-
tion of each insert.
Preparation of DNA. Plasmid DNA was purified from
chloramphenicol-treated E. coli HB101 by alkaline extrac-
tion (1) followed by banding on a CsCI-ethidium bromide
density gradient. DNA for transfection was then dialyzed
against 10 mM Tris hydrochloride (pH 7.6)-i mM EDTA-
0.25 M NaCl and precipitated with ethanol. Recovered DNA
was dissolved in 10 mM Tris hydrochloride (pH 7.6)-i mM
EDTA. DNA concentrations were determined by absorb-
ance at 260 nm and verified by agarose gel electrophoresis-
ethidium bromide staining.
Transient expression assay. Mouse Ltk- cells (27) were
grown as monolayers in Dulbecco modified Eagle medium
(GIBCO Laboratories) containing 10% fetal bovine serum
(GIBCO Laboratories) at 37°C in an atmosphere of 5% CO,
saturated with water. Transfections were by the DEAE-
dextran-dimethyl sulfoxide shock procedure (32) as de-
scribed in detail (59), except that cells were plated at a
density of 5 x 105 cells per plate the day before transfection.
Crude cellular extracts were prepared, and CAT assays were
performed as described (59). Protein concentrations of the
extracts were measured by the method of Bradford (2) with
bovine serum albumin as the standard. Acetylated products
were separated from the labeled chloramphenicol substrate
by thin-layer chromatography (16), and radioactive spots
were identified by autoradiography and quantitated by liquid
scintillation counting. Multiple transfections with two inde-
pendent plasmid preparations were performed for each plas-
mid construction; standard errors of the reported means
were 10%7 or less for transfections performed in the presence
of dexamethasone and 30% or less for transfections per-
formed in the absence of hormone.
DNA sequencing. SaO,3A-Saii3A or Saii3A-HindIII frag-
ments of the MMTV LTRs were subcloned into M13mpl8
and M13mpi9 vectors (38) and sequenced by the dideoxy
chain termination method (55). All reported sequences were
determined on both DNA strands, with the exception of a
few bases just downstream from the 5' Saui3A site which
were sequenced on multiple independent clones but only on
one strand. Dideoxy sequencing to verify the construction of
chimeric LT'Rs was performed on double-stranded plasmid
templates (5) prepared by alkaline extraction (1).
Gel electrophoresis mobility shift assay. Nuclear extracts of
Ltk- cells were made by the method of Dignam et al. (9)
with the following modifications. Cells (108 to 109) were
grown on plates, and the synthetic glucocorticoid dexame-
thasone was added to a final concentration of i0-' M 18 h
before harvest. Cells were washed twice with phosphate-
buffered saline (2.7 mM KCI, 1.5 mM KH PO4, 15 mM
Na,HPO4, 137 mM NaCI) containing 1 mM EDTA, and 0.1%
Triton X-100 was added to the buffer described by Dignam et
al. (9) for cell homogenization. The salt-extracted nuclear
proteins were dialyzed against 20 mM HEPES (N-2-hydrox-
yethylpiperazine-N'-2-ethanesulfonic acid)-20%c (vol/vol)
glycerol-0.1 M KCI-0.2 mM EDTA-0.5 mM dithiothreitol-
0.5 mM phenylmethylsulfonyl fluoride, and the precipitated
material was removed by centrifugation for 10 min at 1,000 x
g at 4°C. Protein concentration of the extract was deter-
mined by the method of Bradford (2) with bovine serum
albumin as a standard.
Complementary 32-base oligonucleotides containing the
NF-1 site (extending from position -84 to -53) were syn-
thesized on an Applied Biosystems DNA Synthesizer and
purified by denaturing polyacrylamide gel electrophoresis.
The sequence was derived from the transcriptionally active
C3H strain of virus and had the sequence 5'-TGTTCTT
TTGGAATTTATCCAAATCTTATGTA-3'. Equal molar
amounts of the complementary strands were mixed and
annealed by heating for 2 min at 100°C and slowly cooling to
room temperature. The resulting double-stranded fragment
was purified by nondenaturing polyacrylamide gel electro-
phoresis and 5'-end labeled to a specific activity of 100 Ci/
mmol with T4 polynucleotide kinase (Bethesda Research
Laboratories) and [y-32P]ATP (New England Nuclear
Corp.). Binding reactions were performed by a modification
of the procedure of Schneider et al. (58). Labeled DNA
fragment (10 fmol) and various amounts of competing DNA
as indicated in the legend to Fig. 6 were incubated with 4 ,ug
of nuclear extract protein for 15 min at room temperature in
25 mM HEPES (pH 7.9)-i mM EDTA-5 mM dithiothreitol-
10% glycerol-150 mM NaCl-67 pg of poly(dI-dC) (Phar-
macia) per ml in a total volume of 15 pl. The reaction
mixture was then loaded on a 4% polyacrylamide gel (29:1,
acrylamide-bisacrylamide) containing 0.04 M Tris acetate
(pH 7.8)-2 mM EDTA-10% glycerol and electrophoresed at
15 V/cm for 0.75 to 1 h in the same buffer (without glycerol).
After electrophoresis the gel was dried and exposed for 16 h
to XAR-5 film (Eastman Kodak Co.) with a Dupont Cronex
Lightning-Plus intensifying screen.
RESULTS
Transcriptional potential of MMTV LTRs endogenous to
C57BL/6 mice. We have previously reported the molecular
cloning and characterization of MMTV DNA endogenous to
C57BL/6 mice (53). This inbred strain contains three appar-
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FIG. 1. MMTV proviral DNA endogenous to C57BL/6 mice. MMTV proviruses at genetic loci Mtv-8, Mt.-9, and Mtv-17 are depicted as
heavy lines with some relevant restriction sites indicated. The molecular cloning of the entire Mtv-8 locus, as well as the 3' portions of Mtv,-9
and Mtv-17, has been previously described (53). An enlargement of the LTR with approximate positions of the GRE, as defined functionally
(3, 4, 22, 29, 34, 54) and by sites of glucocorticoid receptor binding in vitro (47, 56, 57), and the NRE (42) are indicated. The arrow shows
the start site and direction of MMTV transcription. The presence of Aival and BstEII sites in the 5' LTRs of proviruses at Mtv-9 and Mtv-17
has not been verified.
ently intact copies of proviral DNA at genetic loci Mti'-8,
Mtv-9, and Mtv-17 (Fig. 1) (50, 53).
To determine the transcriptional potential of the LTRs of
these endogenous proviruses, analogous AvaI-to-BstEII re-
striction fragments from both LTRs of Mtv-8, as well as from
the 3' LTRs of Mtv-9 and Mtv-17, were cloned into plasmid
pMT2 (42) after modification of the ends to HindIll sites with
synthetic linkers (see Materials and Methods for details of
constructions). Each resulting plasmid was constructed such
that the MMTV promoter within the LTRs could drive
synthesis of the CAT gene product when the plasmids were
introduced into appropriate cultured cells (Fig. 2). The
plasmids have been designated pLV8.5 (containing the 5'
LTR from Mtv-8), pLV8.3 (containing the 3' LTR from
Mtv-8), pLV9.3 (containing the 3' LTR from Mtv-9), and
pLV17.3 (containing the 3' LTR from Mtv- 7).
We have described an extensive characterization of a
transient transfection assay with plasmids similar to these in
which we defined highly reproducible transfection condi-
tions (59). We demonstrated that under these conditions
CAT specific activity measured in crude extracts of trans-
fected cells is linearly related to the quantity of MMTV-CAT
RNA transcripts (59); furthermore, we have shown that four
different plasmid constructions, all of which are related to
those described here, result in an essentially identical aver-
age plasmid copy number of 15 to 30 molecules per nucleus
in a population of transfected Ltk- cells (42, 52).
Each LTR-containing plasmid was transfected into mouse
Ltk- cells by the DEAE-dextran-dimethyl sulfoxide shock
procedure (32) as previously described (59) (Fig. 3). CAT
activity directed by the plasmid containing the 5' LTR from
Mtv-8 (pLV8.5) was more than 100-fold induced by the
synthetic glucocorticoid dexamethasone (Fig. 3, lanes 1 and
2). CAT activity from plasmids containing the 3' LTRs of
Mtv-8 (pLV8.3) and Mtv-9 (pLV9.3) was similarly inducible
(Fig. 3, lanes 3 to 6). In dramatic contrast, CAT activity in
extracts of cells transfected with the plasmid containing the
3' LTR of Mt'-17 (pLV17.3) (Fig. 3, lanes 7 and 8) was
significantly less in the absence of glucocorticoid induction
and was inducible to a level only about 5% of that observed
in extracts of cells transfected with the other three plasmids.
DNA sequence analysis of endogenous MMTV LTRs. The
failure of the 3' LTR from Mtv-17 to direct CAT gene
expression at levels comparable to the other tested LTRs
w
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V 40SV4
FIG. 2. Structure of MMTV LTR-CAT plasmids. Comparable
Avcal-BstEII restriction fragments of endogenous MMTV LTRs
(striped box) were inserted into plasmid pMT2 (42) after converting
the ends to Hindlll sites. The resulting plasmids contain the LTRs
as well as the coding sequences for CAT (filled box) and the simian
virus 40 small-t intron and early poly(A) signals (open box). The
vector sequences are derived from pSVOd (37), a "poisonless" (33)
derivative of pBR322, into which we have inserted a bacteriophage
M13 origin of replication (stippled box) (67) after deletion of the
simian virus 40 origin region. The expected major transcript is
indicated by the arrow. Plasmids pLV8.5 and pLV8.3 contain the 5'
and 3' LTRs from Mtv-8, respectively, pLV9.3 contains the 3' LTR
from Mtv-9, and pLV17.3 contains the 3' LTR from Mtv-17.
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W,won transiently expressed CAT activity (data not shown). It
therefore appears very unlikely that differences in mRNA
stability, processing, or translational efficiency (61) could
explain the lack of CAT expression in cells transfected with
**** * pLV17.3.
Comparison of the DNA sequences, however, suggests
that the lack ofCAT expression from pLV17.3 may be due to
+ + altered transcriptional activity of the Mtv-17 LTR. For
example, a G-to-A difference between the LTRs of Mtv-8
9.3 17.3 and Mtv-17 at position -75 is within the footprint for the
.0o .017 2.28 .0n 0096 transcription factor NF-1, which has been implicated in
hormone-inducible gene expression from MMTV (3, 7, 40,
plasmids containing LTRs from 45); in addition, there are 26 other base differences between
58 h, cell extracts were prepared the two LTRs in the sequenced 5' flanking DNA, some of
hown is an autoradiogram of the which reside in the glucocorticoid receptor footprints de-
-ation of the unacetylated [14C] fined in vitro (47, 56, 57) and within sequences containing the
r spot) from the 3-acetyl and 1- NRE (42).
a representative assay. Numerical Functional analysis of chimeric transcription control re-
it the averages of three to five gions. To analyze separately the potential effects of sequence
o independent plasmid prepara- differences between the various LTRs, we took advantage of
les of chloramphenicol acetylated the conserved Salt3A restriction site at position -114 (Fig.
ct protein. Cells were transfected 4). A CAT expression plasmid was constructed which con-
8.3 (lanes 3 and 4)(pLV9.3 (lanes tamned a chimeric transcription control region composed of
nes 2, 4, 6t and 8) 18 h before Mtv-8 sequences from -457 to -115 and Mtv'-17 sequences
d in the autoradiogram proceeded from -114 through the rest of the LTR to the BstEII site atdtracts of cells not treated with +105 (Fig. SA). Because the Sau3A site at -114 roughly
s of cells treated with dexameth- divides the LTR between the promoter and the GRE, we
have called this plasmid pLV.G8.P17, indicating that the
origin of the GRE is Mtv-8 and the origin of the promoter is
Mtv-17; the only difference in 5' flanking sequences between
,cription, to mRNA instability, this plasmid and a similarly constructed plasmid composed
the MMTV-CAT mRNA. To entirely of Mtv-8 DNA (pLV.G8.P8) is the single G-to-A
ibilities, portions of the endog- difference in the NF-I footprint at position -75. A plasmid
ubcloned into M13mpl8 and containing the converse chimeric transcription control re-
subjected to DNA sequence gion was also constructed with sequences from -457 to
termination method (55). The -115 from Mtv-17 and sequences from -114 to +105 from
approximately -450 to +100 Mtv'-8 (pLV.G17.P8).
gtion start within the MMTV These plasmids were transfected into Ltk- cells to assess
:wn transcriptional regulatory their ability to direct glucocorticoid-inducible expression of
-TR, including the NRE (42), CAT (Fig. SB). Transfection of pLV.G17.P8 (Fig. SB, lanes
d promoter (3, 34, 42, 54). 1 and 2) and pLV.G8.P8 (lanes 5 and 6) resulted in gluco-
d DNA sequences of the four corticoid-induced CAT activity comparable to that observed
ed in Fig. 4. All of the LTR with the complete Mtv-8 LTR (Fig. 3). In contrast, hormone-
ogous to each other and to induced CAT expression in cells transfected with
LTR sequences (10, 11, 26, pLV.G8.P17 was approximately 10-fold lower (Fig. SB,
n the 5' and 3' LTRs of Mtv-8 lanes 3 and 4). It therefore appears that the Mtv-17 GRE is
nly two base differences at functional when linked to a functional promoter but that the
sequence of the 3' LTR of single-base change in the NF-1 footprint of Mtv'-17 signifi-
rerences as compared with a cantly affects the ability of the LTR to respond to the GRE.
e (10), all of which are down- Interestingly, uninduced levels of CAT expression from
start. The 3' LTR of Mtv-9 pLV.G8.P17 were significantly higher than those observed
ie sequences of the two Mtv'-8 when the Mtv-17 promoter was in the context of the entire
R sequence at -260 and the Mtv-17 LTR (pLV17.3, Fig. 3, lane 7) and were comparable
87. The 3' LTR from Mtv'-17 to those observed with pLV.G17.P8 and pLV.G8.P8, which
'R at 28 sites. However, the contain the Mtv-8 promoter (see Discussion).
from +1 to the BstEII site at NF-1 binding to endogenous LTR sequences. To assess
3' LTRs of Mtv'-8 and Mtv'-9, whether the altered NF-I site in Mtv-17 DNA had, indeed,
iajor transcripts from the CAT affected NF-1 binding, we took advantage of a gel electro-
Zs should be identical with the phoresis mobility shift assay (13, 14) similar to that em-
s in the linker DNAs used to ployed by Schneider et al. (58) to detect NF-1 binding in
HindIII site, none of which crude nuclear extracts. The basis of this assay is that
.ion initiation sites into the protein-DNA complexes migrate more slowly during elec-
f related plasmids containing trophoresis than does free DNA. Complementary 32-base
s at an analogous position oligonucleotides containing the NF-1 site (extending fi-om
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M-8 (5) TTCGCCATCCCGTCTCCGGT CGTCACTTATCCTTCACTTT CCAGAGAGTCCCCCCGCAGA CCCCGGTGACC
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t17(37 ....... ...................G...............- .. ...........
FIG. 4. Sequence of transcription control regions of endogenous MMTV LTRs. Sequences were determined by the dideoxy chain
termination method and are numbered relative to the site of transcription initiation (+1). The positions of the Sau3A restriction sites (Fig. 1)
are indicated. The underlined bases represent the sequences related to the consensus NF-1 binding site (TTGGCTNNNAGCCAA) (24); the
previously defined NF-1 footprint extends from -79 to -59 (45). Functional analysis of the GRE has localized it to the region between
approximately -200 and -80 (3, 4, 22, 29, 34, 54), with glucocorticoid receptor footprints located at approximately positions -198 to -164,
-124 to -107, -101 to -88, and -85 to -73 (47, 56, 57). The NRE has been localized to positions -457 to -366 (42).
position -84 to -53) from the transcriptionally active C3H
strain of virus were synthesized, allowed to anneal, and
5'-end labeled with T4 polynucleotide kinase and [-y-
32P]ATP. The sequence of the oligonucleotides differs from
the Mtv-8 sequence at two positions, both of which are
outside the bases related to the NF-1 consensus (see Mate-
rials and Methods). Incubation of this labeled oligonucleo-
tide with a crude nuclear extract of Ltk- cells resulted in the
appearance of a labeled band of reduced electrophoretic
mobility (Fig. 6). The specificity of this retarded band was
verified by competition studies in which unlabeled 32-bp
oligonucleotide was able to compete effectively with the
labeled oligonucleotide for binding, while comparable
amounts of oligonucleotides of similar size that did not
A .t
it _
,-; V. n. 1 .7. P8
LI: V G 3 Pi 7
-457 -4 +4
B
1 2 3 4 5
7t;_P, _
FIG. 5. CAT expression from plasmids containing chimeric tran-
scription control regions. (A) Structures of chimeric transcription
control regions. Sequences derived from Mtv-8 are shown as a
striped box, while those derived from Mtv-17 are shown as a
stippled box. The start site and direction ofMMTV transcription are
indicated by the arrow. Plasmid pLV.G17.P8 contains sequences
from Mtv-17 from -457 to -115 and sequences from Mtv-8 from
-114 to +105, while pLV.G8.P17 has the converse structure.
Plasmid pLV.G8.P8 is composed entirely of sequences from Mtv-8.
(B) CAT expression. A representative autoradiogram of CAT assays
performed and reported as described in the legend to Fig. 3 is
shown. Numerical values of CAT activity represent the averages of
three to five independent transfections with two independent plas-
mid preparations. Extracts were prepared from cells transfected
with pLV.G17.P8 (lanes 1 and 2), pLV.G8.P17 (lanes 3 and 4), and
pLV.G8.P8 (lanes 5 and 6). Dexamethasone (10-7 M) was added to
some transfected cells (lanes 2, 4, and 6) 18 h before harvest. The
CAT assays depicted in the autoradiogram proceeded for 1 h at 37°C
with 40 ig (extracts of cells not treated with dexamethasone) or 5 ,ug
(extracts of cells treated with dexamethasone) of total protein.
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FIG. 6. NF-1 binding to endogenous MMTV LTRs, assessed by
gel electrophoresis mobility shift assay. A 5'-end-labeled, double-
stranded oligonucleotide containing MMTV sequences from -84 to
-53 (10 fmol) was incubated with 4 jig of nuclear extract protein
from Ltk- cells, and the products are displayed as an autoradiogram
after fractionation by polyacrylamide gel electrophoresis. The posi-
tions corresponding to the electrophoretic mobilities of free DNA
(F) and the DNA-NF-1 complex (B) are shown. (A) Competition for
NF-1 binding by pLV.G17.P8. Incubations were performed in the
presence of unlabeled pLV.G17.P8, which contains Mtv-17 se-
quences from -457 to -115 and Mtv-8 sequences from -114 to
+ 105, at molar ratios of 100 (lane 1), 50 (lane 2), 10 (lane 3), 5 (lane
4), and 0 (lane 5) relative to the labeled fragment. Lane 6 contains
DNA with no added nuclear extract. (B) Competition for NF-1
binding by pLV.G8.P17. Incubations were performed in the pres-
ence of unlabeled pLV.G8.P17, which contains Mtv-8 sequences
from -457 to -115 and Mtv-17 sequences from -114 to +105.
Relative amounts of competing DNA are the same as in the
corresponding lanes in panel A.
contain an NF-1 site were not able to compete (data not
shown). In addition, plasmids pLV8.3 (data not shown) or
pLV.Gl7.P8 (Fig. 6A), which contain functional NF-1 sites
from Mtv-8, were able to compete, while pMT1, a plasmid
that contains only the pBR322-derived sequences of the
MMTV-CAT constructions, was not (data not shown). Little
or no competition was observed with pLV.G8.Pl7 (Fig. 6B)
or pLV17.3 (data not shown), indicating that the affinity of
NF-1 for Mtv-17 DNA containing the G-to-A transition is
substantially reduced. Quantitative interpretation of these
experiments is difficult due to the crude nature of the extract
and unknown parameters relating to the kinetics of dissoci-
ation of NF-1-DNA complexes during electrophoresis, but
the results suggest that NF-1 affinity for the altered site is
reduced by at least an order of magnitude.
DISCUSSION
Transcriptional potential of endogenous MMTV LTRs. The
transcriptional inactivity of endogenous MMTV proviral
DNA has been ascribed to position effects of the chromo-
somal context of the integration sites of the proviral units.
Mechanisms related to DNA hypermethylation (6, 19, 21) or
specific patterns of chromatin packaging (12, 51) have been
postulated to explain these effects at a molecular level.
These models predict that functional transcriptional regula-
tory signals within the endogenous proviruses should be
revealed in transfection experiments in which molecular
clones of proviral DNA are freed of their usual chromosomal
context. Our transfection results indicate that the LTRs from
endogenous proviruses at Mtv-8 and Mtv-9 are, indeed,
capable of specifying hormone-induced transcription, and
these results support the idea that position effects play a
major role in determining the transcriptional inactivity of
these proviral units. Similar results have been obtained in
transfection experiments performed with a clone of Mtv-8
DNA isolated from GR mice (8, 23).
In contrast, at least one endogenous provirus with fairly
broad distribution among laboratory strains of mice (28)
contains a transcriptionally defective LTR. We have not
been able to show explicitly that both LTRs of Mtv-17 are
defective, owing to the difficulty in obtaining molecular
clones of the 5' portion of the provirus (53). However, our
results suggest that the lack of transcription of the provirus
at Mtv-17 appears to be due to an inherent transcriptional
defect that affects the DNA sequence element normally
involved in binding NF-1. The DNA sequence alterations in
the Mtv-17 LTR within the GRE and NRE apparently do not
significantly alter the function of these regulatory elements,
as evidenced by their ability to mediate appropriate tran-
scriptional activity when linked to the Mtv-8 promoter (Fig.
5B). Thus, even if the chromosomal context of the Mtv2-17
provirus allowed its functional GRE to be recognized by the
glucocorticoid receptor protein, transcription would not be
induced. Indeed, indirect evidence provided by glucocorti-
coid-inducible sites of nuclease hypersensitivity (51, 68) that
map to the GREs within both LTRs of the Mtv-17 provirus
suggests that these GREs are recognized by the receptor,
even in cell lines in which no MMTV transcription can be
detected (J. Marich and D. Peterson, unpublished observa-
tion).
We have determined that the G-to-A transition in the NF-1
site in Mtv-17 is not specific to the clonal isolate analyzed
here; the identical sequence is also present in an indepen-
dently isolated clone of Mtv-17 DNA (kindly provided by
Jaqueline Dudley).
The portion of the Mtv-17 LTR that we have sequenced
includes a region spanning the C-terminal 73 amino acids of
the 320-amino-acid open reading frame present in the
MMTV LTR (10, 11, 26). Relative to the LTRs from Mtv-8
and Mtv-9, the sequenced portion of the Mtv-17 LTR con-
tains 20 base alterations affecting 18 codons and 13 amino
acids of this reading frame; however, none of these alter-
ations would lead to premature termination of synthesis of
the polypeptide encoded by this region.
NF-1 and MMTV transcription. NF-1 was originally char-
acterized as a cellular protein required for adenovirus repli-
cation in vitro (43), but it has now been shown to interact
with a number of eucaryotic RNA polymerase II promoters
as well, including that of MMTV (45). Recently, construc-
tion and analysis of mutant MMTV promoters has allowed
some transcriptional relevance to be ascribed to this binding.
Buetti and Kuhnel (3) constructed a mutant in which se-
quences between -90 and -70 were deleted and replaced
with a 10-bp synthetic linker, resulting in a decrease in
hormone induction of fivefold, but not affecting basal levels
of transcription. More recently, Miksicek et al. (40) con-
structed a series of insertion mutations that altered the
spacing between the elements of dyad symmetry of the NF-1
site without changing any wild-type nucleotides. These
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mutations decreased hormone-induced transcription as well
as NF-1 binding in vitro; however, their effect could not be
definitively ascribed to changes in NF-I binding because of
simultaneous alterations in the relative spacing of other
transcriptional regulatory sequences. Our analysis of the
naturally occurring defect within the LTR of Mti'-17 estab-
lishes the importance of NF-1 binding for hormone-induced
transcription from the MMTV promoter, and the interpreta-
tion of our results is not complicated by deletion or insertion
of nucleotides into the NF-1 site. Furthermore, the effect of
the point mutation in the Mti-17 NF-i site indicates the
importance of this base in NF-I recognition and transcrip-
tional control. The G residue altered in the Mt.-17 LTR is
highly conserved in both half-sites of symmetrical NF-I
binding sites (18, 20, 24, 30, 44, 45).
It is difficult to reach any definitive conclusions regarding
the role of the NF-1 site in basal promoter activity. The
complete Mtv-17 LTR, which contains sequence alterations
in the NRE and GRE in addition to the altered NF-1 site,
directs a level of CAT activity 10- to 20-fold less than the
LTR from Mt'-8 both in the presence and absence of
dexamethasone (Fig. 3); when the single-base difference in
the NF-I site is isolated from the other divergent sequences,
only hormone-induced CAT expression is affected (Fig. SB).
These observations by themselves suggest that the NF-1 site
may be required only for hormone-induced transcription
from the MMTV promoter. This idea is consistent with the
results of one study in which the NF-i site was included in
the sequences required to confer maximal glucocorticoid
inducibility to the herpes simplex virus thymidine kinase
promoter (54). However, the thymidine kinase promoter
employed in this study contained a deletion of distal se-
quence 2 (36), which contains binding sites for the transcrip-
tion factors SP1 and NF-I (24, 25), and the requirement for
the MMTV NF-1 site in these experiments may simply have
been to partially restore the deleted promoter element.
Interpreting the role of NF-I in basal MMTV transcription is
further complicated by our observation that a number of
mutations introduced into the MMTV NF-I site lead to
decreased transcription both in the presence and absence of
hormone (M.G. Toohey and D. 0. Peterson, manuscript in
preparation), suggesting that NF-I binding is required for
basal, as well as glucocorticoid-induced, promoter activity.
A final determination of the role of NF-1 in basal transcrip-
tion from the MMTV promoter must await a more detailed
analysis of a number of mutant promoters containing altered
NF-1 sites.
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